Deloitte Recap LLCHelping clients navigate the life sciences industry |
Publish date:
In July 2008, Recombinant Capital, Inc. was purchased by Deloitte LLP and is now known as Deloitte Recap LLC (Recap). Recap offers biopharmaceutical business intelligence subscription tools and consulting services tailored toward business development, corporate strategy, financial, legal, academic and R&D professionals.
Products
Recap recently launched a new series of biopharmaceutical business intelligence tools, the Recap IQ Series by Deloitte™. The subscription database products within the new IQ Series provide analytical tools to help Life Sciences companies leverage comprehensive biopharma alliance data, deal values, and drug development histories to support the development of alliance and clinical development strategies. Each of the products within the IQ Series is complementary to each other and can either be purchased separately or bundled together.
The first two premium subscription database products in the IQ Series, DEAL builder™ and VALUATION analyzer™, are biopharma business intelligence tools for managing alliance formation, the lifecycle of the alliance, and deal valuations. Gain new insights into biopharma alliances with access to unredacted, unpublished agreements secured through Freedom of Information Act requests of the U.S. Securities and Exchange Commission.
The third product within the IQ Series, DEVELOPMENT optimizer™, is a groundbreaking business intelligence tool that is changing how clinical development decisions are made. Designed with the same meticulous, data-rich approach that is the hallmark of the Recap brand, DEVELOPMENT optimizer offers new ways to look at attrition, development and regulatory performance, and termination efficiency.
Monthly Webinars
Recap hosts a series of monthly Webinars. The Webinars are free and presented live online. Registration is required. Register for an upcoming Webinar or to access archived Webinar presentations.
Stay Connected: Subscriptions
Sign up to receive the latest insights and ideas from the Deloitte Life Sciences industry practice and the Deloitte Center for Health Solutions.
E-mail | 
RSS ( What is RSS?) | 
Twitter
Recap IQ Series by Deloitte, DEAL builder, VALUATION analyzer, and DEVELOPMENT optimizer are trademarks of Deloitte Recap LLC. As used in this document, ‘Deloitte’ means Deloitte LLP (and its subsidiaries). Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries.
Last updated